Počet záznamov: 1
Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer
Názov Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer Autor Taskoparan Betul Spoluautori Seza Esin Gulce Demirkol Secil Tuncer Sinem Štefek Milan 1950-2023 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS ORCID Gure Ali Osmay Banerjee Sreeparna Zdroj.dok. Cellular Oncology (Dordrecht). Vol. 40, no. 6 (2017), p. 563-578 Jazyk dok. eng - angličtina Krajina NL - Holandsko Druh dok. rozpis článkov z periodík (rbx) Ohlasy DAI, G.-P. - WANG, L.-P. - WEN, Y.-Q. - REN, X.-Q. - ZUO, S.-G. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. In ONCOLOGY LETTERS. ISSN 1792-1074, 2020, vol. 19, no. 1, p. 388-398. YAO, Y.Z. - WANG, X.C. - ZHOU, D.Y. - LI, H. - QIAN, H. - ZHANG, J.W. - JIANG, L.H. - WANG, B. - LIN, Q. - ZHU, X.G. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. In AGING-US. ISSN 1945-4589, 2020, vol. 12, no. 13, p. 13059-13075. KHAYAMI, R. - HASHEMI, S.R. - KERACHIAN, M.A. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential. In JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. ISSN 1582-1838, 2020, vol. 24, no. 16, p. 8890-8902. LV, Y.H. - WANG, Z.Z. - ZHAO, K. - ZHANG, G.K. - HUANG, S. - ZHAO, Y.G. Role of noncoding RNAs in cholangiocarcinoma (Review). In INTERNATIONAL JOURNAL OF ONCOLOGY. ISSN 1019-6439, 2020, vol. 57, no. 1, p. 7-20. LI, X. - YANG, J. - GU, X.Q. - XU, J.H. - LI, H.W. - QIAN, J.X. - CHEN, L. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma. In DNA AND CELL BIOLOGY. ISSN 1044-5498, 2020, vol. 39, no. 7, p. 1322-1327. WU, T.-T. - CHEN, Y.-Y. - CHANG, H.-Y. - KUNG, Y.-H. - TSENG, C.-J. - CHENG, P.-W. AKR1B1-Induced Epithelial-Mesenchymal Transition Mediated by RAGE-Oxidative Stress in Diabetic Cataract Lens. In ANTIOXIDANTS. eISSN: 2076-3921, 2020, vol. 9, no. 4, art. no. 273. KRAUSE, N. - WEGNER, A. Fructose Metabolism in Cancer. In CELLS. eISSN: 2073-4409, 2020, vol. 9, no. 12, art. no. 2635. WANG, X. - KHOSHABA, R. - SHEN, Y. - CAO, Y. - LIN, M.L. - ZHU, Y. - CAO, Z. - LIAO, D.F. - CAO, D.L. Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. In FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. ISSN 2296-634X, 2021, vol. 9, art. no. 632805. SHIMURA, T. - SHARMA, P. - SHARMA, G.G. - BANWAIT, J.K. - GOEL, A. Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer. In SCIENTIFIC REPORTS. ISSN 2045-2322, APR 6 2021, vol. 11, no. 1. GAO, Y.S. - XU, D.Y. - LI, H.W. - XU, J.H. - PAN, Y.T. - LIAO, X.Y. - QIAN, J.X. - HU, Y. - YU, G.Z. Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, MAY 28 2021, vol. 11. ENDO, S. - MATSUNAGA, T. - NISHINAKA, T. The Role of AKR1B10 in Physiology and Pathophysiology. In METABOLITES. JUN 2021, vol. 11, no. 6. HUANG, H. - FU, J.M. - ZHANG, L. - XU, J. - LI, D.P. - ONWUKA, J.U. - ZHANG, D. - ZHAO, L.Y. - SUN, S.M. - ZHU, L. - ZHENG, T. - JIA, C.Y. - CUI, B.B. - ZHAO, Y.S. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, JUN 11 2021, vol. 11. HOJNIK, M. - GRAZIO, S.F. - VERDENIK, I. - RIZNER, T.L. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. In CANCERS. JUL 2021, vol. 13, no. 14. XU, W.J. - GAO, Y. - ZHANG, J.Q. - ZHANG, R. - CHEN, Q.H. AKR1B10 expression in benign prostatic hyperplasia and its related mechanism. In ONCOLOGY LETTERS. ISSN 1792-1074, SEP 2021, vol. 22, no. 3. XIONG, Z. - LIN, Y. - YU, Y. - ZHOU, X.H. - FAN, J. - ROG, C.J. - CAI, K.L. - WANG, Z. - CHANG, Z.J. - WANG, G.B. - TAO, K.X. - CAI, M. Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, SEP 8 2021, vol. 11. BUKUM, Neslihan - NOVOTNA, Eva - MORELL, Anselm - ZELAZKOVA, Jana - LASTOVICKOVA, Lenka - CERMAKOVA, Lucie - PORTILLO, Ramon - SOLICH, Petr - WSOL, Vladimir. Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib. In BIOCHEMICAL PHARMACOLOGY. ISSN 0006-2952, 2021, vol. 192, no., pp. Dostupné na: https://doi.org/10.1016/j.bcp.2021.114710. SHAO, Xinyu - WU, Jue - YU, Shunying - ZHOU, Yuqing - ZHOU, Chunli. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. In AGING-US. ISSN 1945-4589, 2021, vol. 13, no. 18, pp. 22298-22314. VOLF, Jiri - RAJOVA, Jana - BABAK, Vladimir - SEIDLEROVA, Zuzana - RYCHLIK, Ivan. Detoxification, Hydrogen Sulphide Metabolism and Wound Healing Are the Main Functions That Differentiate Caecum Protein Expression from Ileum of Week-Old Chicken. In ANIMALS. ISSN 2076-2615, 2021, vol. 11, no. 11, pp. Dostupné na: https://doi.org/10.3390/ani11113155. HOJNIK, Marko - SUSTER, Natasa Kenda - SMRKOLJ, Spela - SISINGER, Damjan - GRAZIO, Snjezana Frkovic - VERDENIK, Ivan - RIZNER, Tea Lanisnik. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. In CANCERS, 2022, vol. 14, no. 3, pp. Dostupné na: https://doi.org/10.3390/cancers14030809. JI, Jie - JIN, Dandan - XU, Minxue - JIAO, Yujie - WU, Yue - WU, Tong - LIN, Renjie - ZHENG, Wenjie - LIU, Zhaoxiu - JIANG, Feng - FAN, Yihui - XIAO, Mingbing. AKR1B1 promotes pancreatic cancer metastasis by regulating lysosome-guided exosome secretion. In NANO RESEARCH, 2022, vol. 15, no. 6, pp. 5279-5294. ISSN 1998-0124. Dostupné na: https://doi.org/10.1007/s12274-022-4167-z. WANG, Shiqi - SU, Yuekai - LI, Jingyu - LU, Yongping - MEI, Xiangui - WANG, Jianhua. Integration of LC/MS-based molecular networking and molecular docking allows in-depth annotation and prediction of the metabolome: A study of Salvia miltiorrhiza Bunge. In INDUSTRIAL CROPS AND PRODUCTS, 2022, vol. 186, no., pp. ISSN 0926-6690. Dostupné na: https://doi.org/10.1016/j.indcrop.2022.115298. SUN, X.J. - SUN, S.S. Cardamonin Counteracts Hypoxia-Induced Proliferation, Epithelial-Mesenchymal Transition (EMT) and Apoptosis Inhibition in Pancreatic Cancer Cells through Downregulating Aldo-Keto Reductase 1 Member B1 (AKR1B1). In JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. ISSN 0393-974X, JUL-AUG 2022, vol. 36, no. 4, p. 1079-1089. Dostupné na: https://doi.org/10.23812/j.biol.regul.homeost.agents.20223604.118. BAILLY, C. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer. In EUROPEAN JOURNAL OF PHARMACOLOGY. ISSN 0014-2999, SEP 15 2022, vol. 931. Dostupné na: https://doi.org/10.1016/j.ejphar.2022.175191. ALLEGRINI, S. - GARCIA-GIL, M. - PESI, R. - CAMICI, M. - TOZZI, M.G. The Good, the Bad and the New about Uric Acid in Cancer. In CANCERS. OCT 2022, vol. 14, no. 19. Dostupné na: https://doi.org/10.3390/cancers14194959. WU, J.D. - ZHANG, L. - KUCHI, A. - OTOHINOYI, D. - HICKS, C. CpG Site-Based Signature Predicts Survival of Colorectal Cancer. In BIOMEDICINES. DEC 2022, vol. 10, no. 12. Dostupné na: https://doi.org/10.3390/biomedicines10123163. SUBESKA, A. - ALTHAUS, J. - HAKE, T. - HANEKAMP, W. - BETTENWORTH, D. - MULAC, D. - LANGER, K. - LEHR, M. Synthesis and pharmacokinetic properties of novel cPLA2? inhibitors with 1-(carboxyalkylpyrrolyl)-3-aryloxypropan-2-one structure br. In BIOORGANIC & MEDICINAL CHEMISTRY. ISSN 0968-0896, JAN 1 2023, vol. 77. Dostupné na: https://doi.org/10.1016/j.bmc.2022.117110. AZIZ, M. - EJAZ, S.A. - TAMAM, N. - SIDDIQUE, F. A comprehensive computational approach for the identification of structure-based potential pharmacological candidates as selective AKR1B1 and AKR1B10 inhibitors: repurposing of purine alkaloids for the treatment of cancer. In JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. ISSN 0739-1102, NOV 2 2023, vol. 41, no. 16, p. 7892-7912. Dostupné na: https://doi.org/10.1080/07391102.2022.2127906. TUNER, S. - GURBANOV, R. Non-growth inhibitory doses of dimethyl sulfoxide alter gene expression and epigenetic pattern of bacteria. In APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. ISSN 0175-7598, JAN 2023, vol. 107, no. 1, p. 299-312. Dostupné na: https://doi.org/10.1007/s00253-022-12296-0. ZHAO, Z.Y. - HAO, Z.B. - ZHANG, Z. - ZHAN, X.B. Bioinformatics Analysis Reveals the Vital Role of AKR1B1 in Immune Infiltration and Clinical Outcomes of Gastric Cancer. In DNA AND CELL BIOLOGY. ISSN 1044-5498, JUL 1 2023, vol. 42, no. 7, p. 372-389. Dostupné na: https://doi.org/10.1089/dna.2022.0644. DUAN, W.Z. - LIU, W.W. - XIA, S.K. - ZHOU, Y. - TANG, M.Y. - XU, M.X. - LIN, M.Q. - LI, X.Y. - WANG, Q. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. In JOURNAL OF TRANSLATIONAL MEDICINE. AUG 16 2023, vol. 21, no. 1. Dostupné na: https://doi.org/10.1186/s12967-023-04403-0. LIU, L.J. - ZHU, L.H. - CHENG, Z.W. - SUN, Y.B. - ZHOU, Y.Q. - CAO, J.W. Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway. In AGING-US. ISSN 1945-4589, SEP 30 2023, vol. 15, no. 18, p. 9661-9675. LU, J.P. - KANG, T. - ZHANG, Z.L. Diagnostic value of aldo-keto reductase family 1 member B10 in human nasopharyngeal carcinoma. In MOLECULAR AND CLINICAL ONCOLOGY. ISSN 2049-9450, NOV 2023, vol. 19, no. 5. Dostupné na: https://doi.org/10.3892/mco.2023.2685. YAO, H.B. - HU, J.F. - SHAO, Y.F. - SHAO, Q.S. - ZHENG, S.S. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5. In TURKISH JOURNAL OF GASTROENTEROLOGY. DEC 2023, vol. 34, no. 12`. Dostupné na: https://doi.org/10.5152/tjg.2023.22555. LIAO, Y.Q. - MAO, H.Y. - GAO, X. - LIN, H.L. - LI, W.Y. - CHEN, A. - LI, H.W. Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss. In FREE RADICAL BIOLOGY AND MEDICINE. ISSN 0891-5849, JAN 2024, vol. 210, p. 430-447. Dostupné na: https://doi.org/10.1016/j.freeradbiomed.2023.11.025. SARFRAZ, M. - AZIZ, M. - AFZAL, S. - CHANNAR, P.A. - ALSFOUK, B.A. - KANDHRO, G.A. - HASSAN, S. - SULTAN, A. - HAMAD, A. - ARAFAT, M. - QAISER, M.N. - AHMED, A. - SIDDIQUE, F. - EJAZ, S.A. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis. In PROTEIN JOURNAL. ISSN 1572-3887, APR 2024, vol. 43, no. 2, p. 207-224. Dostupné na: https://doi.org/10.1007/s10930-023-10163-z. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2017 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1007/s13402-017-0351-7 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Opposing roles of the aldo-keto reductases AKR1B1.pdf Neprístupný/archív 5.1 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2017 2016 3.786 Q1 1.199 Q1
Počet záznamov: 1